Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Xinya Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5856-347X; OpenAlex author ID A5078540419. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 2 papers · 2026: 1 paper

Papers 3

  1. Lipid Nanoparticle-Based αHTRA1 mRNA Improves Pancreatic Ductal Adenocarcinoma Redox Microenvironment by Suppressing HTRA1/HIF-1 Signaling. Co-author DOI 10.1021/acs.bioconjchem.6c00013↗
  2. Targeted mitochondrial therapy for pancreatic cancer. Co-author DOI 10.1016/j.tranon.2025.102340↗
  3. Roles of nucleotide metabolism in pancreatic cancer. Co-author DOI 10.3389/fimmu.2025.1637768↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xufeng Tao · 2 shared papers, 2025–2026 · strength 0.64
  2. Deshi Dong · 2 shared papers, 2025–2026 · strength 0.64
  3. Jing Liu · 1 shared paper, 2025 · strength 0.33
  4. Fangyue Guo · 1 shared paper, 2026 · strength 0.32
  5. Xiaonan Zhang · 1 shared paper, 2026 · strength 0.32
  6. Quanlin Liu · 1 shared paper, 2025 · strength 0.30
  7. Lei Wang · 1 shared paper, 2025 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.